These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24076307)

  • 1. Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practice.
    Chipman JJ; Sanda MG; Dunn RL; Wei JT; Litwin MS; Crociani CM; Regan MM; Chang P;
    J Urol; 2014 Mar; 191(3):638-45. PubMed ID: 24076307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Use of Expanded Prostate Cancer Index Composite for Clinical Practice to Assess Patient Reported Prostate Cancer Quality of Life Following Robot-Assisted Radical Prostatectomy.
    Wagner AA; Cheng PJ; Carneiro A; Dovirak O; Khosla A; Taylor KN; Crociani CM; McAnally KC; Percy A; Dewey LE; Sanda MG; Chang P
    J Urol; 2017 Jan; 197(1):109-114. PubMed ID: 27475967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial comment.
    Smith A
    J Urol; 2014 Mar; 191(3):645. PubMed ID: 24291118
    [No Abstract]   [Full Text] [Related]  

  • 4. Portuguese version of the Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP): psychometric validation and prospective application for early functional outcomes at a single institution.
    Lourenço DB; Amaral BS; Alfer-Junior W; Vasconcellos A; Russo F; Sanchez-Salas R; Bianco B; Wagner AA; Chang P; Moschovas MC; Lemos GC; Carneiro A
    BMC Urol; 2020 Oct; 20(1):163. PubMed ID: 33081748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer.
    Katz A; Ferrer M; Suárez JF;
    Radiat Oncol; 2012 Nov; 7():194. PubMed ID: 23164305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early postoperative urinary and sexual function predicts functional recovery 1 year after prostatectomy.
    Ellison JS; He C; Wood DP
    J Urol; 2013 Oct; 190(4):1233-8. PubMed ID: 23608677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-reported health-related quality of life outcomes after HDR brachytherapy between small (<60 cc) and large (≥60 cc) prostate glands.
    Press RH; Morgan TM; Cutrell PK; Zhang C; Chen Z; Rahnema S; Sanda M; Pattaras J; Patel P; Jani AB; Rossi PJ
    Brachytherapy; 2019; 18(1):13-21. PubMed ID: 30262410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Internal Validation of a Web-based Tool to Predict Sexual, Urinary, and Bowel Function Longitudinally After Radiation Therapy, Surgery, or Observation.
    Laviana AA; Zhao Z; Huang LC; Koyama T; Conwill R; Hoffman K; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg MR; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Penson DF; Barocas DA
    Eur Urol; 2020 Aug; 78(2):248-255. PubMed ID: 32098731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
    Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors.
    Szymanski KM; Wei JT; Dunn RL; Sanda MG
    Urology; 2010 Nov; 76(5):1245-50. PubMed ID: 20350762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External validation of predictive models of sexual, urinary, bowel and hormonal function after surgery in prostate cancer subjects.
    Borg MA; O'Callaghan ME; Moretti KL; Vincent AD
    BMC Urol; 2024 Jan; 24(1):2. PubMed ID: 38166977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life after robot-assisted radical prostatectomy compared with laparoscopic radical prostatectomy.
    Koike H; Kohjimoto Y; Iba A; Kikkawa K; Yamashita S; Iguchi T; Matsumura N; Hara I
    J Robot Surg; 2017 Sep; 11(3):325-331. PubMed ID: 28130703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quality of life in patients with prostate cancer: validation of an instrument for clinical practice].
    Balbontín F; Marchetti P; Moreno S; Cabello JM; Urzúa C; Silva A; Avilés J; Badínez L; García J; Salgado A; Vinez E; Alliende I; Canals A; Velasco A
    Arch Esp Urol; 2015 Jun; 68(5):466-73. PubMed ID: 26102050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of expanded prostate cancer index composite (EPIC) quality of life after surgery or radiation treatment.
    Lee TK; Breau RH; Mallick R; Eapen L
    Can J Urol; 2015 Feb; 22(1):7599-606. PubMed ID: 25694006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanded Prostate Cancer Index Composite versus Incontinence Symptom Index and Sexual Health Inventory for Men to measure functional outcomes after prostatectomy.
    Hedgepeth RC; Labo J; Zhang L; Wood DP
    J Urol; 2009 Jul; 182(1):221-7; discussion 227-8. PubMed ID: 19450842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.
    Wei JT; Dunn RL; Litwin MS; Sandler HM; Sanda MG
    Urology; 2000 Dec; 56(6):899-905. PubMed ID: 11113727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective assessment of time-dependent changes in quality of life of Japanese patients with prostate cancer following robot-assisted radical prostatectomy.
    Miyake H; Miyazaki A; Furukawa J; Hinata N; Fujisawa M
    J Robot Surg; 2016 Sep; 10(3):201-7. PubMed ID: 26885662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpretation of Domain Scores on the EPIC-How Does the Domain Score Translate into Functional Outcomes?
    Laviana AA; Hernandez A; Huang LC; Zhao Z; Koyama T; Conwill R; Hoffman K; Feurer ID; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg MR; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Penson DF; Barocas DA
    J Urol; 2019 Dec; 202(6):1150-1158. PubMed ID: 31216252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life in men with localized prostate cancer treated with radiotherapy: validation of an abbreviated version of the Expanded Prostate Cancer Index Composite for Clinical Practice in Spain.
    Zapatero A; Maldonado Pijoan X; Gómez-Caamaño A; Pardo Masferrer J; Macías Hernández V; Hervás Morón A; Muñoz García JL; Palacios Eito A; Anguita-Alonso P; González-Junco C; López Torrecilla J
    Health Qual Life Outcomes; 2021 Sep; 19(1):223. PubMed ID: 34563208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and Morbidity of Local Treatment-Related Side Effects in Metastatic Prostate Cancer Patients.
    Sentana-Lledo D; Dodge LE; Chang P; Einstein DJ
    Urol Oncol; 2023 Apr; 41(4):204.e1-204.e6. PubMed ID: 36754665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.